These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20018412)

  • 1. [Treatment with (131)I of thyroid remnants in a patient with papillary thyroid carcinoma and end-stage chronic renal failure].
    Andres A; Tardín L; Santapau A; Razola P; Prats E; Parra A; Rivas MA; Ruiz P; Alvarez R; Camara A; Banzo J
    Rev Esp Med Nucl; 2010; 29(1):32-5. PubMed ID: 20018412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of thyroid papillary carcinoma with radioiodine in a patient with end stage renal disease on hemodialysis.
    Mello AM; Isaacs R; Petersen J; Kronenberger S; McDougall IR
    Clin Nucl Med; 1994 Sep; 19(9):776-81. PubMed ID: 7982310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Occult papillary thyroid carcinoma in thyroglossal cyst diagnosed by (18)FDG PET/CT scan].
    Serrano Vicente J; Infante Torre JR; Rayo Madrid JI; García Bernardo L; Domínguez Grande ML; Durán Barquero C; Sánchez Sánchez R
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):229-30. PubMed ID: 22980131
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic strategy of papillary microcarcinoma of the thyroid gland: a nuclear medicine perspective.
    Riemann B; Schober O
    Minerva Endocrinol; 2009 Mar; 34(1):81-7. PubMed ID: 19209130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-131 treatment of thyroid papillary carcinoma in patients undergoing dialysis for chronic renal failure: a dosimetric method.
    Jiménez RG; Moreno AS; Gonzalez EN; Simón FJL ; Rodriguez JR; Jimenez JC; Córdoba MH; Albertino RV; Jimenez RA
    Thyroid; 2001 Nov; 11(11):1031-4. PubMed ID: 11762712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
    Rashid K; Johns W; Chasse K; Walker M; Gupta SM
    Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis.
    Daumerie C; Vynckier S; Caussin J; Jadoul M; Squifflet JP; de Patoul N; Wambersie A
    Thyroid; 1996 Aug; 6(4):301-4. PubMed ID: 8875750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (131)I treatment in Differentiated Thyroid Cancer and End-Stage Renal Disease.
    Ortega AJ; Vázquez RG; Cuenca JI; Brocca MA; Castilla J; Martínez JM; González EN
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):29-33. PubMed ID: 26144699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.
    Muratet JP; Daver A; Minier JF; Larra F
    J Nucl Med; 1998 Sep; 39(9):1546-50. PubMed ID: 9744340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diffuse sclerosing variant of papillary thyroid carcinoma].
    Manrique Franco K; Domínguez Fernández R; Lara Capellán JI; Renedo Pascual G; Rovira Loscos A
    Endocrinol Nutr; 2010 Dec; 57(10):500-2. PubMed ID: 20843752
    [No Abstract]   [Full Text] [Related]  

  • 11. Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.
    Muratet JP; Giraud P; Daver A; Minier JF; Gamelin E; Larra F
    J Nucl Med; 1997 Sep; 38(9):1362-8. PubMed ID: 9293788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of well-differentiated thyroid cancer with end-stage renal disease.
    Wang TH; Lee CH; Tseng LM; Liu RH
    Endocrine; 2003 Aug; 21(3):227-31. PubMed ID: 14515006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 131I treatment of thyroid papillary carcinoma in a patient with renal failure.
    Morrish DW; Filipow LJ; McEwan AJ; Schmidt R; Murland KR; von Westarp C; Betcher KB
    Cancer; 1990 Dec; 66(12):2509-13. PubMed ID: 2249192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism.
    Ringel MD; Ladenson PW
    J Clin Endocrinol Metab; 1996 May; 81(5):1724-5. PubMed ID: 8626823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.
    Elisei R; Schlumberger M; Driedger A; Reiners C; Kloos RT; Sherman SI; Haugen B; Corone C; Molinaro E; Grasso L; Leboulleux S; Rachinsky I; Luster M; Lassmann M; Busaidy NL; Wahl RL; Pacini F; Cho SY; Magner J; Pinchera A; Ladenson PW
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4171-9. PubMed ID: 19850694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid remnant ablation in patients with papillary cancer: a comparison of low, moderate, and high activities of radioiodine.
    Kusacic Kuna S; Samardzic T; Tesic V; Medvedec M; Kuna K; Bracic I; Despot M; Dodig D
    Nucl Med Commun; 2009 Apr; 30(4):263-9. PubMed ID: 19247212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma.
    Silberstein EB
    J Nucl Med; 2007 Jul; 48(7):1043-6. PubMed ID: 17574976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine 131 ablation therapy for a patient on maintenance haemodialysis.
    Howard N; Glasser M
    Br J Radiol; 1981 Mar; 54(639):259. PubMed ID: 7470791
    [No Abstract]   [Full Text] [Related]  

  • 20. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.